Xeris Biopharma Holdings Market Sentiment

Xeris Biopharma Holdings Inc

XERSNASDAQ

Trade with Public

$9.98

0.151.53%

近くで: Sep 28, 5:00 PM EST

$10.00

0.171.73%

プレマーケット: 4:40 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Xeris Biopharma Holdings Market Sentiment

Market sentiment signals for Xeris Biopharma Holdings (XERS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 4.6% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

8 analysts

Options Flow (P/C)

—

Avg Consensus PT

$11

+11.3%

Highest Price Target

$18

+80.0%

Oppenheimer

Lowest Price Target

-40.0%

Jefferies

Short Interest

4.6%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 10, 2026	Leerink Partners	Roanna Ruiz—	+60.0%	$12 → $16	Maintained	Outperform
Aug 20, 2026	Barclays	Glen Santangelo—	+20.0%	$9 → $12	Maintained	Overweight
Mar 2, 2026	HC Wainwright & Co.	Brandon Folkes—	+0.0%	$10 → $10	Maintained	Buy
Jan 9, 2026	HC Wainwright & Co.	Brandon Folkes—	+0.0%	$10 → $10	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	-10.0%	$9	Initiate	Overweight
Nov 7, 2025	Oppenheimer	Leland Gershell—	+80.0%	$18 → $18	Maintained	Outperform
Nov 7, 2025	HC Wainwright & Co.	Brandon Folkes—	+0.0%	$10 → $10	Maintained	Buy
Nov 7, 2025	Piper Sandler	David Amsellem—	-20.0%	$6 → $8	Maintained	Neutral
Oct 29, 2025	Oppenheimer	Leland Gershell—	+80.0%	$8 → $18	Maintained	Outperform
Sep 17, 2025	HC Wainwright & Co.	Brandon Folkes—	+0.0%	$10 → $10	Maintained	Buy
Aug 19, 2025	Leerink Partners	Roanna Ruiz—	-10.0%	$7 → $9	Maintained	Outperform
Aug 12, 2025	HC Wainwright & Co.	Brandon Folkes—	+0.0%	$10	Assumes	Buy
Aug 8, 2025	Craig-Hallum	Chase Knickerbocker—	+10.0%	$7 → $11	Maintained	Buy
Aug 8, 2025	Oppenheimer	Leland Gershell—	-20.0%	$7 → $8	Maintained	Outperform
Jun 5, 2025	Leerink Partners	Roanna Ruiz—	-30.0%	$6 → $7	Maintained	Outperform
May 9, 2025	Oppenheimer	Leland Gershell—	-30.0%	$6 → $7	Maintained	Outperform
Mar 7, 2025	Oppenheimer	Leland Gershell—	-40.0%	$5 → $6	Maintained	Outperform
Mar 7, 2025	Leerink Partners	Roanna Ruiz—	-40.0%	$5 → $6	Maintained	Outperform
Mar 7, 2025	Craig-Hallum	Chase Knickerbocker—	-35.0%	$5 → $7	Maintained	Buy
Mar 7, 2025	Piper Sandler	David Amsellem—	-60.0%	$3 → $4	Maintained	Neutral
Mar 7, 2025	HC Wainwright & Co.	Oren Livnat—	-20.0%	$7 → $8	Maintained	Buy
Jan 29, 2025	Jefferies	Glen Santangelo—	-40.0%	$4 → $6	Maintained	Buy
Nov 11, 2024	HC Wainwright & Co.	Oren Livnat—	-34.0%	$6 → $7	Maintained	Buy
Nov 11, 2024	Piper Sandler	David Amsellem—	-70.0%	$3 → $3	Downgrade	Overweight→Neutral
Aug 15, 2024	HC Wainwright & Co.	Oren Livnat—	-40.0%	$6 → $6	Maintained	Buy